HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert A Koeppe Selected Research

Atrophy

11/2023Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
12/2015APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.
11/2013Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.
1/2013The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
8/20103D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert A Koeppe Research Topics

Disease

35Alzheimer Disease (Alzheimer's Disease)
01/2024 - 12/2003
33Parkinson Disease (Parkinson's Disease)
01/2023 - 12/2003
21Dementia (Dementias)
01/2020 - 12/2003
16Cognitive Dysfunction
01/2023 - 05/2009
12Pain (Aches)
01/2023 - 06/2002
7Migraine Disorders (Migraine)
01/2023 - 06/2014
5Atrophy
11/2023 - 08/2010
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2006
4Headache (Headaches)
01/2023 - 06/2014
4Movement Disorders (Movement Disorder)
11/2022 - 11/2006
3REM Sleep Behavior Disorder
01/2024 - 04/2012
3Disease Progression
01/2022 - 09/2015
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
12/2022 - 01/2020
2Hypokinesia (Bradykinesia)
01/2021 - 05/2013
2Tremor (Tremors)
01/2021 - 05/2013
2Hyperalgesia
04/2017 - 06/2014
2Leukoaraiosis
12/2014 - 05/2013
2Neoplasms (Cancer)
07/2013 - 03/2010
2Gliosarcoma
07/2013 - 03/2010
2Parkinsonian Disorders (Parkinsonism)
04/2012 - 11/2006
1Multiple System Atrophy
11/2022
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Opiate Overdose
03/2020
1Hallucinations (Hallucination)
01/2020
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
10/2019
1Tauopathies
10/2019
1Diarrhea
10/2019
1Mental Disorders (Mental Disorder)
01/2019
1Major Depressive Disorder (Major Depressive Disorders)
01/2019
1Gliosis
12/2018
1Heart Failure
12/2018
1Tourette Syndrome (Tourette's Syndrome)
07/2017
1Heart Diseases (Heart Disease)
01/2017
1Disorders of Excessive Somnolence (Hypersomnia)
08/2016
1Cerebral Cortical Thinning
11/2013
1Prodromal Symptoms
01/2013
1Myalgia
08/2012

Drug/Important Bio-Agent (IBA)

21Biomarkers (Surrogate Marker)IBA
11/2023 - 09/2006
21Amyloid (Amyloid Fibrils)IBA
11/2023 - 05/2010
21Cholinergic Agents (Cholinergics)IBA
01/2023 - 12/2003
15Opioid Analgesics (Opioids)IBA
01/2023 - 06/2002
13dihydrotetrabenazineIBA
12/2014 - 06/2004
11Dopamine (Intropin)FDA LinkGeneric
01/2023 - 10/2006
9AcetylcholinesteraseIBA
01/2023 - 12/2003
9Glucose (Dextrose)FDA LinkGeneric
11/2013 - 01/2008
8carfentanil (carfentanyl)IBA
01/2019 - 11/2003
7Opioid Receptors (Opioid Receptor)IBA
01/2023 - 06/2002
6Neurotransmitter Agents (Neurotransmitter)IBA
01/2023 - 06/2002
6Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA
01/2023 - 07/2017
6mu Opioid Receptors (mu Opioid Receptor)IBA
03/2020 - 06/2002
62- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2014 - 08/2010
6Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
05/2013 - 09/2006
4fluoroethoxy-benzovesamicolIBA
12/2022 - 01/2020
4PropionatesIBA
01/2022 - 06/2010
4florbetapirIBA
10/2021 - 10/2012
4RacloprideIBA
04/2017 - 09/2007
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2012 - 02/2005
3Serotonin (5 Hydroxytryptamine)IBA
01/2024 - 01/2012
3ApolipoproteinsIBA
11/2023 - 01/2013
3Apolipoproteins E (ApoE)IBA
11/2023 - 01/2013
3LigandsIBA
01/2022 - 12/2012
3CarbonIBA
12/2012 - 02/2008
3Analgesics (Analgesic Drugs)IBA
02/2008 - 06/2002
27- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2023 - 01/2020
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
11/2022 - 12/2012
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2022 - 01/2006
2ButyrylcholinesteraseIBA
12/2006 - 01/2006
1Amyloid beta-PeptidesIBA
01/2024
1salicylhydroxamic acid (SHAM)IBA
01/2023
1Indicators and Reagents (Reagents)IBA
01/2023
1Dopamine Agonists (Dopamine Agonist)IBA
01/2022
14- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
10/2021
1Cholinergic ReceptorsIBA
01/2021
1Cholinergic Antagonists (Anticholinergics)IBA
01/2021
1Receptor for Advanced Glycation End ProductsIBA
10/2020
1Naloxone (Narcan)FDA LinkGeneric
03/2020
1Prion ProteinsIBA
10/2019
1saracatinibIBA
10/2019
1Phosphotransferases (Kinase)IBA
10/2019
1Peptides (Polypeptides)IBA
10/2019
1Tetrabenazine (Nitoman)FDA Link
01/2019
1tau Proteins (tau Protein)IBA
01/2019
1Fluorine-18IBA
01/2019
1Carbon-11IBA
01/2019
1Monoamine Oxidase (MAO)IBA
12/2018
1Clarithromycin (Biaxin)FDA LinkGeneric
08/2016
1Apolipoprotein E4IBA
04/2015
1Deoxyglucose (2 Deoxy D glucose)IBA
11/2013
1SolutionsIBA
07/2013
1EmulsionsIBA
07/2013
1Levodopa (L Dopa)FDA LinkGeneric
05/2013
13-hydroxyephedrineIBA
10/2012

Therapy/Procedure

18Denervation
01/2022 - 11/2006
6Sympathectomy (Sympathectomies)
01/2022 - 11/2006
5Therapeutics
12/2018 - 06/2005
2Activities of Daily Living (ADL)
10/2019 - 09/2006
2Analgesia
06/2014 - 02/2008
1Aftercare (After-Treatment)
01/2023
1Transcranial Direct Current Stimulation
01/2023
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2018